AzTrials
AzTrials

Achilles TendinopathyAchTendNCT05677204

Influencing Factors of Acute Achilles Tendinopathy in Runners

An observational study of Achilles Tendinopathy, run by Laval University at 1 site in Canada.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Achilles tendinopathy is highly prevalent in runners, but its evolution is not easily predictable. The aim of this study is to evaluate the impact of clinical and social factors on the prognosis of acute (less than 3 months) Achilles tendinopathy in runners. Runners will be evaluated in person twice. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Achilles Tendinopathy
How many people
95 participants
Where
1 siteCanada
Study dates
1 Jun 2022to Dec 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Runners from Québec city region with Achilles tendon pain for less than three months

Who may be able to join

  • Have Achilles tendon pain for less than three months
  • Run at least five kilometers per week
  • Have a score on the Victorian Institute of Sports Assessment of Achilles tendinopathy of 80 or less
  • Consent to the study

Who cannot join

  • History of Achilles tendon surgery or rupture

Trial locations and contacts

1 site in 1 country.

Canada1 site, 1 recruiting
  • Center for Interdisciplinary Research in Rehabilitation and Social Integration (CIRRIS)

    Québec, Quebec, G1M 2S8

    Jean-Sébastien Roy, PT, PhD, 1-418-529-9141 ext. 6005, jean-sebastien.roy@fmed.ulaval.ca

    Recruiting

Other trials in Canada

About this study

Official title: Factors Predicting the Course of Acute Achilles Tendinopathy in Runners

Achilles tendinopathy is highly prevalent in runners, but its evolution is not easily predictable. The aim of this study is to evaluate the impact of clinical and social factors on the prognosis of acute (less than 3 months) Achilles tendinopathy in runners. Runners will be evaluated in person twice. At their first visit, data related to their training (frequency, intensity, …), their running pattern (cadence, foot contact angle) and shoes (minimalist index) will be collected. Moreover, an ultrasound evaluation of Achilles tendon will be performed. At one, two and three months after their initial evaluation, participants will receive a link to complete an online survey about their pain. Three months after their initial evaluation, a second ultrasound of Achilles tendon will be performed.

Read the detailed description

At their first visit, participants will read and sign the consent form. They will then fill self-report questionnaires about their pain (using the Victorian Institute of Sport Assessment for Achilles tendinopathy score and visual analog scale) and its impact on their activities, and they will be questioned on their training habits. Then, participants will be asked to run on a treadmill for five minutes at a comfortable speed. During the run, video will be recorded to evaluate to cadence and the foot contact angle. Finally, an ultrasound of Achilles tendon will be performed to evaluate thickness, area, echogenicity and inflammation of the tendon. All the images will be revised by a physician qualified in diagnostic ultrasound and the tendinopathy will be graded according to Matthew and al. model.

One, two and three months after their initial visit, participants will receive a questionnaire by email to quantify their pain. Moreover, three months after their initial visit, participants will come back in person to the laboratory. Information about their pain, training and treatment will be collected and a second ultrasound analysis will be performed.

Statistical analysis: Baseline data will be compared using independent t-test or a Mann-Whitney U test. Significant variables in the univariate analysis will be considered as potential predictor variables. Logistic analysis regression will then be performed to identify predictive factors for pain chronicity.

Keywords
Runners, Acute, Prognosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT05677204
Study groupRoleWhat they receive
Acute Achilles tendinopathyNo intervention will be given

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain graded on the visual analog scale

    Pain graded on a 0 to 10 visual analog scale

    Measured: At three months

  2. Victorian Institute of Sports Assessment for Achilles tendinopathy (VISA-A) questionnaire

    Pain impact score between 0 (heavily affected) and 100 (asymptomatic)

    Measured: At three months

Secondary outcomes (3)
  1. Thickness of the Achilles tendon

    Ultrasound evaluation of the tendon

    Measured: At three months

  2. Area of the Achilles tendon

    Ultrasound evaluation of the tendon

    Measured: At three months

  3. Aspect of the tendon at ultrasound evaluation graded according to Matthew and al

    Ultrasound evaluation of the tendon

    Measured: At three months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jan 2023
  2. Study start1 Jun 2022
  3. Primary completion30 Jun 2023
  4. Study completionDec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
95 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05677204
Sponsor's protocol ID
2021-2162, _RIS
Acronym
AchTend
Status last verified
Dec 2023
First submitted
22 Dec 2022
Last updated
11 Dec 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Altman AR, Davis IS. A kinematic method for footstrike pattern detection in barefoot and shod runners. Gait Posture. 2012 Feb;35(2):298-300. doi: 10.1016/j.gaitpost.2011.09.104. Epub 2011 Nov 8.

    PubMed 22075193
  • Esculier JF, Dubois B, Dionne CE, Leblond J, Roy JS. A consensus definition and rating scale for minimalist shoes. J Foot Ankle Res. 2015 Aug 19;8:42. doi: 10.1186/s13047-015-0094-5. eCollection 2015.

    PubMed 26300981
  • Matthews W, Ellis R, Furness JW, Rathbone E, Hing W. Staging achilles tendinopathy using ultrasound imaging: the development and investigation of a new ultrasound imaging criteria based on the continuum model of tendon pathology. BMJ Open Sport Exerc Med. 2020 Mar 25;6(1):e000699. doi: 10.1136/bmjsem-2019-000699. eCollection 2020.

    PubMed 32341798

Questions about this trial

What is this clinical trial studying?

An observational study of Achilles Tendinopathy, run by Laval University at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jean-Sebastien Roy, PT,PhD (1-418-529-9141 ext. 6005, jean-sebastien.roy@fmed.ulaval.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain graded on the visual analog scale (time frame: At three months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05677204, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Dec 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in